NCT03905837View on ClinicalTrials.gov

Impact of Lidocaine Administration on Postoperative Complications During Lung Resection Surgery

PHASE4CompletedINTERVENTIONAL
Enrollment

156

Participants

Timeline

Start Date

January 28, 2019

Primary Completion Date

June 2, 2021

Study Completion Date

July 2, 2021

Conditions
Lung DiseasesLung InflammationLung Injury, AcutePostoperative Complications
Interventions
DRUG

Lidocaine

Intravenous or paravertebral lidocaine

DRUG

Remifentanil

intravenous remifentanil

Trial Locations (1)

28007

Hospital Gregorio Maranon, Madrid

All Listed Sponsors
collaborator

Instituto de Salud Carlos III

OTHER_GOV

lead

Francisco Andres de la Gala

OTHER

NCT03905837 - Impact of Lidocaine Administration on Postoperative Complications During Lung Resection Surgery | Biotech Hunter | Biotech Hunter